- Home
- VTRS vs CLH Comparison
VTRS vs CLH Comparison
Compare VTRS & CLH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- CLH
- Stock Information
- Founded
- VTRS 1961
- CLH 1980
- Country
- VTRS United States
- CLH United States
- Employees
- VTRS N/A
- CLH N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- CLH Environmental Services
- Sector
- VTRS Health Care
- CLH Industrials
- Exchange
- VTRS Nasdaq
- CLH Nasdaq
- Market Cap
- VTRS 11.0B
- CLH 10.3B
- IPO Year
- VTRS N/A
- CLH 1987
- Fundamental
- Price
- VTRS $8.68
- CLH $197.08
- Analyst Decision
- VTRS Hold
- CLH Strong Buy
- Analyst Count
- VTRS 4
- CLH 8
- Target Price
- VTRS $10.50
- CLH $259.25
- AVG Volume (30 Days)
- VTRS 17.7M
- CLH 472.4K
- Earning Date
- VTRS 05-08-2025
- CLH 04-30-2025
- Dividend Yield
- VTRS 5.53%
- CLH N/A
- EPS Growth
- VTRS N/A
- CLH 6.76
- EPS
- VTRS N/A
- CLH 7.42
- Revenue
- VTRS $14,739,300,000.00
- CLH $5,889,952,000.00
- Revenue This Year
- VTRS N/A
- CLH $5.50
- Revenue Next Year
- VTRS $0.99
- CLH $5.83
- P/E Ratio
- VTRS N/A
- CLH $26.57
- Revenue Growth
- VTRS N/A
- CLH 8.89
- 52 Week Low
- VTRS $8.62
- CLH $186.54
- 52 Week High
- VTRS $13.55
- CLH $267.11
- Technical
- Relative Strength Index (RSI)
- VTRS 29.72
- CLH 40.04
- Support Level
- VTRS $9.01
- CLH $197.73
- Resistance Level
- VTRS $9.35
- CLH $202.49
- Average True Range (ATR)
- VTRS 0.27
- CLH 4.29
- MACD
- VTRS 0.00
- CLH 1.73
- Stochastic Oscillator
- VTRS 5.56
- CLH 66.08
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.